Apr 25, 2024 · At PathAI, we’re dedicated to improving patient outcomes with reliable AI-Powered technology and meaningful collaboration with biopharma and pathology laboratories — aiming to provide invaluable insights for biomarker discovery and drug development, and to improve laboratory workflows.

PathAI's Boston, MA headquarters is located right in the heart of Fenway. Our gorgeous office is fully outfitted with drinks and snacks, game room, roof deck, and is in a great location both for commuting and checking out local restaurants and activities.

Boston, MA – September 19, 2023 – PathAI, a global leader in AI-powered pathology, today announced the expansion of its BioPharma Laboratory Services. Capitalizing on the 30-year history of delivering high quality pathology services in the PathAI Diagnostics clinical laboratory (formerly known as Poplar Healthcare), PathAI offers biopharma ...

BOSTON — March 9, 2023 — PathAI, a global leader in AI-powered pathology, today announced the launch of AISight TM, PathAI’s digital pathology platform, and the AIM-PD-L1 NSCLC RUO algorithm 1, which quantitates the percent of PD-L1 positive tumor and immune cells in non-small cell lung cancer (NSCLC) samples across the whole slide image ...

Our mission at PathAI is to improve patient outcomes with AI-powered pathology through: More Accurate Diagnosis Matching Patients with the Most Effective Treatments

BOSTON — August 17, 2023 — PathAI, a global leader in AI-powered pathology, today announced the commercial launch of its AISight TM digital pathology image management system (IMS) for anatomic pathology laboratories. 1 The launch comes at a time when the pathology space is increasingly transitioning to digitally-enabled reads and ...

Boston, MA – November 2, 2023 – PathAI, a leading provider of precision pathology solutions, today announced the formation of a new advisory network to inform the company’s vision to leverage AI-powered digital pathology to improve outcomes for individuals with non-alcoholic steatohepatitis/metabolic dysfunction-associated steatohepatitis ...

BOSTON — June 14, 2023 — PathAI, a leading provider of AI-powered pathology tools to advance precision medicine, today announced that Matt Grow has joined as president of biopharma and chief business officer. The role will support PathAI’s expanding biopharma commercial organization with a focus on the company’s growing algorithm ...

BOSTON, MA – May 9, 2024 – PathAI co-founder and CEO Andy Beck, MD, PhD, has been named to the Boston Globe’s third annual Tech Power Players 50, a list of the most influential – and interesting – people in the New England technology scene, as ranked by The Boston Globe’s business journalists and an external advisory committee.

Boston, MA – February 13, 2024 – PathAI Inc., a leading AI-powered pathology company, today announced an expanded and exclusive relationship with Roche Tissue Diagnostics (RTD) that will bring AI-enabled interpretation to companion diagnostics.